Rankings
▼
Calendar
ELUT Q1 2025 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena
ELUT
Elutia Inc.
$48M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
-9.9% YoY
Gross Profit
$2M
40.7% margin
Operating Income
-$8M
-131.4% margin
Net Income
-$4M
-65.2% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
+10.3%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$39M
Total Liabilities
$76M
Stockholders' Equity
-$36M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$7M
-9.9%
Gross Profit
$2M
$3M
-13.6%
Operating Income
-$8M
-$8M
+6.6%
Net Income
-$4M
-$18M
+78.1%
Revenue Segments
Women's Health
$3M
89%
Cardiovascular
$326,000
11%
← Q4 2024
All Quarters
Q2 2025 →